September 2022 - Page 15 of 26

FridaySep 16, 2022 11:30 am

Trucking Supply Chain Tech Innovator Freight Technologies Inc. (NASDAQ: FRGT) Reports New Revenue Growth on B2B Marketplace Solution

Cross-border shipping solutions developer Freight Technologies Inc. is a B2B marketplace builder focused on providing the commercial trucking industry with transparent and efficient automation to simplify necessary communications, coordination and paperwork Freight Technologies, also known as Fr8Tech, upgraded its brand and ticker symbol earlier this year following its reverse merger with Hudson Capital Inc. Amid the upgrade, the company is reporting new record quarterly revenue that grew by 60 percent over the previous quarter and 45 percent YOY The company expects improving market conditions as the nation continues to rebound from COVID’s economic effects to drive long-term growth At the…

FridaySep 16, 2022 11:00 am

DGE, 3rd Next-Gen MSL Excellence Summit To Prepare MSLs for Better Work Opportunities

Taking place November 2-3, 2022 in Philadelphia, the 3rd Next-Gen MSL Excellence Summit empowers Medical Science Liaisons with all the scientific data tools and customer outreach skills they need to build successful relationships with all stakeholders. The faculty of industry leaders will help attendees refine their approach to Key Opinion Leaders and clearly, convincingly communicate it with patients throughout the product life cycle. Registering for this event gains you an all-access pass to 3 programs in 1! Attendees can also learn and network in discussions and sessions from the 6th Digital Strategy & Innovation for Medical Affairs Summit or the 2nd Investigator-Initiated…

FridaySep 16, 2022 10:58 am

QualityStocksNewsBreaks – Advanced Container Technologies Inc. (ACTX) Featured on ‘Gamechangers LIVE’

Advanced Container Technologies (OTC: ACTX) was featured in a recent episode of “Gamechangers LIVE.” The podcast series shines a spotlight on individuals who are gamechangers in their fields and shares perspective on their journeys, mindsets, struggles and successes in an effort to inspire and inform listeners. Doug Heldoorn, ACTX chairman and CEO, and Shannon Illingworth joined the broadcast, hosted by executive coach and speaker Sergio Tigera, to discuss the origins of Advanced Container Technologies and the ways it is working to revolutionize farming practices. “When I was speaking with Shannon – I’ve known him for 15 years – we were…

FridaySep 16, 2022 10:46 am

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Demonstrates Large-Scale Coherence

D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services, has published a peer-reviewed milestone study of the first large-scale demonstration of coherent quantum annealing. For the first time, the research exhibits dynamics of a quantum phase transition in a large-scale programmable quantum annealing processor using up to 2000 qubits in a D-Wave processor. The announcement reads, “The paper---a collaboration between scientists from D-Wave, the University of Southern California, the Tokyo Institute of Technology, and Saitama Medical University---entitled ‘Coherent quantum annealing in a programmable 2000-qubit Ising chain,’ was published in the peer-reviewed journal Nature Physics today and is…

FridaySep 16, 2022 10:30 am

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Poised to Drive RNG-Led Energy Transition; Reports Q2 2022 Results and Highlights

EverGen reveals Q2 2022 financials and key growth milestones for expansion across Canada Company acquired a 50% interest in Project Radius and a 67% interest in GrowTEC; agreed term sheet for CAD$31 million Senior Term Loan Facility with lenders Roynat and EDC EverGen remains primed for a catalyst-rich second half of 2022; appears on track to boost RNG production to satisfy Canada’s swelling demand as consumers flock to the renewable natural gas space "We have positioned EverGen as a leading RNG platform with a core operating portfolio and pipeline of projects in Canada set to deliver significant RNG volumes and…

FridaySep 16, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX), Growing its Market Share, One Patent at a Time

Lexaria’s development of its patented DehydraTECH(TM) technology since 2014 has yielded 27 patents in Australia, the United States, the European Union, Japan, India and Mexico with approximately 50 additional patents pending around the world Its latest patent, granted in Mexico, applies a range of active ingredients, including but not limited to non-psychoactive cannabinoids and NSAIDs in a variety of ready-to-drink consumer retail beverage products Lexaria remains committed to advancing its research and expanding the indications and efficacy of its DehydraTECH technology, as it looks to benefit from the CBD industry, projected to be valued at $111.8 billion by 2030, and…

FridaySep 16, 2022 9:00 am

Research from D-Wave Quantum Inc. (NYSE: QBTS) Demonstrates Large-Scale Coherent Quantum Annealing

D-Wave has announced first ever demonstration of large-scale coherence in quantum annealers New research findings open the door to simulations of exotic phases of matter (unusual states of matter, outside of liquid, solid or gas, that make up the universe) The company is further exploring the potential of annealing quantum computing for future products, services, and software applications D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, is focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials science, drug discovery, scheduling, fault detection, and financial modeling, and is…

ThursdaySep 15, 2022 3:03 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (SILOD) Implements Reverse Stock Split in Preparation for Nasdaq Uplisting

Silo Pharma (OTCQB: SILOD), a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it will effect a 1-for-50 reverse split of its common stock. Effective at the open of business on Thursday, Sept. 15, 2022, the reverse stock split is in preparation for the planned listing of the company’s securities on the Nasdaq Capital Market (“Nasdaq”). The company’s common stock has begun trading on the OTC Markets system on a split-adjusted basis under the temporary ticker symbol SILOD. The fifth character “D” will remain appended to Silo Pharma’s symbol for 20 business days or…

ThursdaySep 15, 2022 2:54 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Secures Expanded Contract with Oregon-Based Client

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced that a locally owned, Oregon-based healthcare system has expanded its contract for its many facilities in the state. The announcement reads, “On the heels of securing a contract for a Knightscope K5 Autonomous Security Robot (‘ASR’), the new client has increased its order for an additional 2 K5 ASRs. The client has a children’s hospital, a 24-hour mental and behavioral health services center, and more than 70 primary care, specialty and urgent care clinics. The hospital’s goal is to deter criminal activity,…

ThursdaySep 15, 2022 1:34 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Hypertension Treatment Program Stands Distinct

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently provided information to its stakeholders to help them conveniently research and understand different non-affiliated third-party sources and their methodologies for valuing biotech and pharmaceutical companies. The information includes a discussion of underlying logic-based evaluations that offer a realistic framework of expectations that investors can use in their analysis. “One of the logic-based evaluations considers the stage at which a company’s drug development program has reached. According to the U.S. Food and Drug Administration (‘FDA’), there are five steps to the drug development process: discovery and development, preclinical research, clinical research, FDA drug review, and,…

Site Search

Company Search

Month: September 2022